2023 Brown Pathology Travel Award Winners

We are pleased to announce the winners of the 2023 Brown Pathology Travel Award:

  • Yigit Baykara, MD (PGY 3) - Protein-Protein Interactions in Papillary and FollicularThyroid Carcinomas
  • Mohammed Omer, MD (PGY 2) – IPSS-M Improves the Risk Stratification of MDS Patients: A Single Institution Experience
  • Evi Abada, MD, MS (Stuart Lauchlan Fellow) – Low Level Expression of Human Epidermal Growth Factor-2 (HER2) in High-Grade Mullerian Tumors: Implications For Therapy Decision Making
  • Jessica Posada, MD, PhD (Surgical Pathology Fellow) – Characterizing the Genomic Landscape of Micropapillary Variant of Urothelial Carcinoma of the Bladder Harboring Activating Extra-Cellular Mutations of the ERBB2 Gene

We would like to thank our Brown Pathology Travel Award Selection Committee members for their efforts: Mariana Canepa, Shaza Ben Khadra, Katrine Hansen, Sean Lawler, Sara Maleki, Joyce Ou, Michael Punsoni, Mohammed Quddus, Kamaljeet Singh, Evgeny Yakirevich, Alisha Lima (Coordinator).
Diana O. Treaba, Director of Brown Pathology Residency Program
Jesse L. Hart, Associate Director of Brown Pathology Residency Program
Geralyn M. Lambert-Messerlian, Vice Chair for Clinical Faculty Development
Liang Cheng, Vice Chair for Translational Research

Dr. Anatoly Zhitkovich-Expert Evaluator at the Integrated Risk Information System (IRIS) Program Public Science Meeting on 1/11/23

Dr. Anatoly Zhitkovich served as the National Academy of Sciences (NAS) selected expert to evaluate EPA's Plan to conduct Integrated Risk Information System (IRIS)  Assessment of Inhalation Exposure to Cobalt and Cobalt Compounds. The EPA held a public meeting on this topic on 1-11-23 where Dr. Zhitkovich gave two presentations. The first presentation was on the "Association Between Lung and Adrenal Tumor Formation" and the second was on "Proposed MOA of Cobalt Carcinogenicity."

Cancer Drug Resistance Interview with Dr. Wafik El-Deiry

On December 1, 2022, the Editorial Office of Cancer Drug Resistance (CDR) was very honored to interview Journal Editorial Board member Prof. Wafik S. El-Deiry, who is Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Director of the Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown University and Affiliated Hospitals, Providence, RI, USA.

In the interview, Prof. El-Deiry shared what motivated him to enter the field of oncology research, research advances, and challenges in the field. In addition, he shared that the original discovery of p21 is one of the most exciting things in his career. p21 was the first mammalian CDK inhibitor to be discovered, which eventually led to the discovery and development of a new class of now FDA approved CDK inhibitor drugs. Furthermore, he also gave some advice to young researchers. He stressed that young researchers should really consider pursuing oncology research when they do have some interest and skills on it. He said that they can really make a difference in the world. Finally, he talked about how cancer drug resistance is very important and has huge challenges, and hoped that we could continue making important progress.

View the complete interview at the link below:

CDR Interview with Dr. El-Deiry






News from Women & Infants Hospital

1. Geralyn Messerlian, PhD, Professor of Pathology and Laboratory Medicine, CNE
Director of Clinical Chemistry and Special Testing, is appointed Vice Chair for Clinical
Faculty Development of the Department of Pathology of Warren Alpert Medical School
of Brown University effective August 10, 2022.
2. C. James Sung, MD, led an international team of College of American Pathologists
(CAP) inspectors conducted a virtual CAP inspection of the Department of Laboratory
Medicine of the First Hospital of China Medical University in Shenyang, Liaoning, China
on August 23-24, 2022.
3. The Microbiology Lab welcomes Amy Arruda, MLS(ASCP) as our new Microbiology
Lab Manager. Amy started 8/22/22. She joined us from the Beth Israel Deaconess
Plymouth Hospital.
4. The Department welcomes Steffanie C. Tamayo, MD, as our Visiting International
Fellow in Women’s Pathology. Dr. Tamayo joins us from the St. Luke’s Hospital in
Manila, Philippines. She will be with us until June 30, 2023.
5. Zhenwei Zhang, MDPhD, currently a pathology resident at the University of
Massachusetts, Worcester, is selected as the next Stuart Lauchlan Fellow in Gynecologic
Pathology and Breast Pathology in 2024-2025